Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The completed Phase 3 pembrolizumab trial record is displayed with study design, treatment arms, outcomes, eligibility criteria, locations, publications, and results-related resources.
    Difference
    100%
    Check dated 2026-11-07T13:56:03.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site revision label updates from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:38:02.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the unchanged 403 error page.
    Difference
    1%
    Check dated 2026-10-24T15:16:43.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page displays a newer site revision number, changing from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:57:01.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T15:49:36.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Access to the study's main content is now blocked by a 403 Forbidden page, replacing the usual trial details. This prevents users from viewing core information about the trial on the public page.
    Difference
    18%
    Check dated 2026-09-19T18:20:21.000Z thumbnail image

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.